Plant Fatty Acid Synthases and Use in Improved Methods for Production of Medium-Chain Fatty Acids

ABSTRACT

By this invention, compositions and methods of use related to β-ketoacyl-ACP synthase Of special interest are synthases obtainable from  Cuphea  species. Amino acid and nucleic acid for synthase protein factors are provided, as well as methods to utilize such sequences in constructs for production of genetically engineered plants having altered fatty acid compositions. Of particular interest is the expression of synthase protein factors in conjunction with expression of plant medium-chain acyl-ACP thioesterases for production of increased levels and/or modified ratios of medium-chain fatty acids in oils of transgenic plant seeds.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 10/635,822, filed Aug. 7, 2003, which is a divisional of U.S. patent application Ser. No. 09/057,996, filed Apr. 9, 1998, which claims the benefit under 35 U.S.C. §119(e) of U.S. Patent Application Ser. No. 60/0471,815, filed Apr. 11, 1997. U.S. application Ser. Nos. 10/635,822 and 09/057,996 are herein incorporated by reference in their entirety.

INCORPORATION OF SEQUENCE LISTING

A paper copy of the Sequence Listing and a computer readable form of the sequence listing on diskette, containing the file named 16518131seq(ASFILED).txt, which is 54,544 bytes in size (measured in MS-DOS), and which was created on Aug. 7, 2003, is herein incorporated by reference in its entirety.

FIELD OF INVENTION

The present invention is directed to genes encoding plant fatty acid synthase enzymes relevant to fatty acid synthesis in plants, and to methods of using such genes in combination with genes encoding plant medium-chain preferring thioesterase proteins. Such uses provide a method to increase the levels of medium-chain fatty acids that may be produced in seed oils of transgenic plants.

BACKGROUND

Higher plants synthesize fatty acids via a common metabolic pathway. In developing seeds, where fatty acids attached to triglycerides are stored as a source of energy for further germination, the fatty acid synthesis pathway is located in the plastids. The first step is the formation of acetyl-ACP (aryl carrier protein) from acetyl-CoA and ACP catalyzed by a short chain preferring condensing enzyme, β-ketoacyl-ACP synthase (KAS) III. Elongation of acetyl-ACP to 16- and 18-carbon fatty acids involves the cyclical action of the following sequence of reactions: condensation with a two-carbon unit from malonyl-ACP to form a longer β-ketoacyl-ACP (β-ketoacyl-ACP synthase), reduction of the keto-function to an alcohol (β-ketoacyl-ACP reductase), dehydration to form an enoyl-ACP (β-hydroxyacyl-ACP dehydrase), and finally reduction of the enoyl-ACP to form the elongated saturated acyl-ACP (enoyl-ACP reductase). β-ketoacyl-ACP synthase I (KAS I), is primarily responsible for elongation up to palmitoyl-ACP (C16:0), whereas β-ketoacyl-ACP synthase II (KAS II) is predominantly responsible for the final elongation to stearoyl-ACP (C18:0).

Genes encoding peptide components of β-ketoacyl-ACP synthases I and II have been cloned from a number of higher plant species, including castor (Ricinus communis) and Brassica species (U.S. Pat. No. 5,510,255). KAS I activity was associated with a single synthase protein factor having an approximate molecular weight of 50 kD (synthase factor B) and KAS II activity was associated with a combination of two synthase protein factors, the 50 kD synthase factor B and a 46 kd protein designated synthase factor A. Cloning and sequence of a plant gene encoding a KAS III protein has been reported by Tai and Jaworski (Plant Physiol. (1993) 103:1361-1367).

The end products of plant fatty acid synthetase activities are usually 16- and 18-carbon fatty acids. There are, however, several plant families that store large amounts of 8- to 14-carbon (medium-chain) fatty acids in their oilseeds. Recent studies with Umbellularia californica (California bay), a plant that produces seed oil rich in lauric acid (12:0), have demonstrated the existence of a medium-chain-specific isozyme of acyl-ACP thioesterase in the seed plastids. Subsequent purification of the 12:0-ACP thioesterase from Umbellularia californica led to the cloning of a thioesterase cDNA which was expressed in seeds of Arabidopsis and Brassica resulting in a substantial accumulation of lauric acid in the triglyceride pools of these transgenic seeds (U.S. Pat. No. 5,512,482). These results and subsequent studies with medium-chain thioesterases from other plant species have confirmed the chain-length-determining role of acyl-ACP thioesterases during de novo fatty acid biosynthesis (T. Voelker (1996) Genetic Engineering, Ed. J. K. Setlow, Vol. 18, pgs. 111-133).

DESCRIPTION OF THE FIGURES

FIG. 1. DNA (SEQ ID NO: 1) and translated amino acid sequence (SEQ ID NO: 2) of Cuphea hookeriana KAS factor B clone chKAS B-2 are provided.

FIG. 2. DNA (SEQ ID NO: 3) and translated amino acid sequence (SEQ ID NO: 4) of Cuphea hookeriana KAS factor B clone chKAS B-31-7 are provided.

FIG. 3. DNA (SEQ ID NO: 5) and translated amino acid sequence (SEQ ID NO: 6) of Cuphea hookeriana KAS factor A clone chKAS A-2-7 are provided.

FIG. 4. DNA (SEQ ID NO: 7) and translated amino acid sequence (SEQ ID NO: 8) of Cuphea hookeriana KAS factor A clone chKAS A-1-6 are provided.

FIG. 5. DNA (SEQ ID NO: 9) and translated amino acid sequence (SEQ ID NO: 10) of Cuphea pullcherrima KAS factor B clone cpuKAS B/7-8 are provided.

FIG. 6. DNA (SEQ ID NO: 11) and translated amino acid sequence (SEQ ID NO: 12) of Cuphea pullcherrima KAS factor B clone cpuKAS B/8-7A are provided.

FIG. 7. DNA (SEQ ID NO: 13) and translated amino acid sequence (SEQ ID NO: 14) of Cuphea pullcherrima KAS factor A clone cpuKAS A/p7-6A are provided.

FIG. 8. Preliminary DNA sequence (SEQ ID NO: 15) of Cuphea pullcherrima KAS factor A clone cpuKAS A/p8-9A is provided.

FIG. 9. DNA (SEQ ID NO: 16) and translated amino acid sequence (SEQ ID NO: 17) of Cuphea hookeriana KASIII clone chKASIII-27 are provided.

FIG. 10. The activity profile for purified cpuKAS B/8-7A using various acyl-ACP substrates is provided.

FIG. 11. The activity profile for purified chKAS A-2-7 and chKAS A-1-6 using various acyl-ACP substrates is provided.

FIG. 12. The activity profile for purified castor KAS factor A using various acyl-ACP substrates is provided.

FIG. 13. The activity profile for purified castor KAS factor B using various acyl-ACP substrates is provided.

FIG. 14. A graph showing the number of plants arranged according to C8:0 content for transgenic plants containing CpFatB1 versus transgenic plants containing CpFatB1+chKAS A-2-7 is provided.

FIG. 15A. Graph showing the % C10% C8 ratio in transgenic plants resulting from cross of plants containing ChFatB2 (4804-22-357) and 5401-9 (chKAS A-2-7 plants) is provided.

FIG. 15B. Graph showing the % C10% C8 ratio in transgenic plants containing ChFatB2 (4804-22-357) is provided.

FIG. 16A. Graph showing the % C10+% C8 content in transgenic plants resulting from cross of plants containing ChFatB2 (4804-22-357) and 5401-9 (chKAS A-2-7 plants) is provided.

FIG. 16B. Graph showing the % C10+% C8 content in transgenic plants containing ChFatB2 (4804-22-357) is provided.

FIG. 17A. Graph showing the % C10% C8 ratio in transgenic plants resulting from cross of plants containing ChFatB2 (4804-22-357) and 5413-17 (chKAS A-2-7+CpFatB1 plants) is provided.

FIG. 17B. Graph showing the % C10% C8 ratio in transgenic plants containing ChFatB2 (4804-22-357) is provided.

FIG. 18A. Graph showing the % C10+% C8 content in transgenic plants resulting from cross of plants containing ChFatB2 (4804-22-357) and 5413-17 (chKAS A-2-7+CpFatB1 plants) is provided.

FIG. 18B. Graph showing the % C10+% C8 content in transgenic plants containing ChFatB2 (4804-22-357) is provided.

FIG. 19A. Graph showing the % C12:0 in transgenic plants containing Uc FatB1 (LA86DH186) is provided.

FIG. 19B. Graph showing the % C12:0 in transgenic plants resulting from cross of plants containing Uc FatB1 (LA86DH186) and wild type (X WT) is provided.

FIG. 19C. Graph showing the % C12:0 in transgenic plants resulting from cross of plants containing Uc FatB1 (LA86DH186) and lines expressing Ch KAS A-2-7 is provided.

FIG. 20. Graph showing the relative proportions of C12:0 and C14:0 fatty acids in the seeds of transgenic plants containing Uc FatB1 (LA86DH186) and in plants resulting from crosses with wild type (X WT) and with lines expressing Ch KAS A-2-7.

FIG. 21A. Gaph showing the % C18:0 in transgenic plants containing Garm FatB1 (5266) is provided.

FIG. 21B. Graph showing the % C18:0 in transgenic seeds resulting from cross of plants containing Garm FatB1 (5266) and wild type (X WT) is provided.

FIG. 21C. Graph showing the % C18:0 in transgenic seeds of plants resulting from cross of plants containing Garm FatB1 (5266) and lines expressing Ch KAS A-2-7 is provided.

FIG. 22. The activity profile of Ch KAS A in protein extracts from transgenic plants containing Ch KAS A-2-7. Extracts were preptreated with the indicated concentrations of cerulenin.

SUMMARY of THE INVENTION

By this invention, compositions and methods of use related to β-ketcacyl-ACP synthase (KAS) are provided. Also of interest are methods and compositions of amino acid and nucleic acid sequences related to biologically active plant synthase(s).

In particular, genes encoding KAS protein factors A and B from Cuphea species are provided. The KAS genes are of interest for use in a variety of applications, and may be used to provide synthase I and/or synthase II activities in transformed host cells, including bacterial cells, such as E. coli, and plant cells. Synthase activities are distinguished by the preferential activity towards longer and shorter acyl-ACPs as well as by the sensitivity towards the KAS specific inhibitor, cerulenin. Synthase protein preparations having preferential activity towards medium chain length acyl-ACPs are synthase I-type or KAS I. The KAS I class is sensitive to inhibition by cerulenin at concentrations as low as 1 μM. Synthases having preferential activity towards longer chain length acyl-ACPs are synthase II-type or KAS II. The KAS enzymes of the II-type are also sensitive to cerulenin, but at higher concentrations (50 μM). Synthase III-type enzymes have preferential activity towards short chain length acyl-ACPs and are insensitive to cerulenin inhibition.

Nucleic acid sequences encoding a synthase protein may be employed in nucleic acid constructs to modulate the amount of synthase activity present in the host cell, especially the relative amounts of synthase I-type, synthase II-type and synthase III-type activity when the host cell is a plant host cell. In addition, nucleic acid constructs may be designed to decrease expression of endogenous synthase in a plant cell as well. One example is the use of an anti-sense synthase sequence under the control of a promoter capable of expression in at least those plant cells which normally produce the enzyme.

Of particular interest in the present invention is the coordinate expression of a synthase protein with the expression of thioesterase proteins. For example, coordinated expression of synthase factor A and a medium-chain thioesterase provides a method for increasing the level of medium-chain fatty acids which may be harvested from transgenic plant seeds. Furthermore, coordinated expression of a synthase factor A gene with plant medium-chain thioesterase proteins also provides a method by which the ratios of various medium-chain fatty acids produced in a transgenic plant may be modified. For example, by expression of a synthase factor A, it is possible to increase the ratio of C10/C8 fatty acids which are produced in plant seed oils as the result of expression of a thioesterase having activity on C8 and C10 fatty acids.

DETAILED DESCRIPTION OF THE INVENTION

A plant synthase factor protein of this invention includes a sequence of amino acids or polypeptide which is required for catalyzation of a condensation reaction between an acyl-ACP having a chain length of C₂ to C₁₆ and malonyl-ACP in a plant host cell. A particular plant synthase factor protein may be capable of catalyzing a synthase reaction in a plant host cell (for example as a monomer or homodimer) or may be one component of a multiple peptide enzyme which is capable of catalyzing a synthase reaction in a plant host cell, i.e. one peptide of a heterodimer.

Synthase I (KAS I) demonstrates preferential activity towards acyl-ACPs having shorter carbon chains, C₂-C₁₄ and is sensitive to inhibition by cerulenin at concentrations of 1 μM. Synthase II (KAS II) demonstrates preferential activity towards acyl-ACPs having longer carbon chains, C₁₄-C₁₆, and is inhibited by concentrations of cerulenin (50 μM). Synthase III demonstrates preferential activity towards acyl-CoAs having very short carbon chains, C₂ to C₆, and is insensitive to inhibition by cerulenin.

Synthase factors A and B, and synthase III proteins obtained from medium-chain fatty acid producing plant species of the genus Cuphea are described herein. As described in the following Examples, synthase A from C. hookeriana is naturally expressed at a high level and only in the seeds. C. hookeriana synthase B is expressed at low levels in all tissues examined. Expression of synthase A and synthase B factors in E. coli and purification of the resulting proteins is employed to determine activity of the various synthase factors. Results of these analyses indicate that synthase factor A from Cuphea hookeriana has the greatest activity on 6:0-ACP substrates, whereas synthase factor B from Cuphea pullcherrima has greatest activity on 14:0-ACP. Similar studies with synthase factors A and B from castor demonstrate similar activity profiles between the factor B synthase proteins from Cuphea and castor. The synthase A clone from castor, however, demonstrates a preference for 14:0-ACP substrate.

Expression of a Cuphea hookeriana KAS A protein in transgenic plant seeds which normally do not produce medium-chain fatty acids does not result in any detectable modification of the fatty acid types and contents produced in such seeds. However, when Cuphea hookeriana KAS A protein is expressed in conjunction with expression of a medium-chain acyl-ACP thioesterase capable of providing for production of C8 and C10 fatty acids in plant seed oils, increases in the levels of medium-chain fatty acids over the levels obtainable by expression of the medium-chain thioesterase alone are observed. In addition, where significant amounts of C8 and C10 fatty acids are produced as the result of medium-chain thioesterase expression, co-expression of a Cuphea KAS A protein also results in an alteration of the proportion of the C8 and C10 fatty acids that are obtained. For example, an increased proportion of C10 fatty acids may be obtained by co-expression of Cuphea hookeriana ChFatB2 thioesterase and a chKAS A synthase factor proteins.

Furthermore, when Cuphea hookeriana KAS A protein is expressed in conjunction with expression of a medium-chain acyl-ACP thioesterase capable of providing for production of C12 fatty acids in plant seed oils, increases in the levels of medium-chain fatty acids over the levels obtainable by expression of the medium-chain thioesterase alone are also observed. In addition, where significant amounts of C12 and C14 fatty acids are produced as the result of medium-chain thioesterase expression, co-expression of a Cuphea KAS A protein also results in an alteration of the proportion of the C12 and C14 fatty acids that are obtained. For example, an increased proportion of C12 fatty acids may be obtained by co-expression of Uc FatB1 thioesterase and a chKAS A synthase factor proteins.

However, when Cuphea hookeriana KAS A protein is expressed in conjunction with the expression of a long-chain acyl-ACP thioesterase capable of providing for production of C18 and C18:1 fatty acids in plant seed oils, no effect on the production of long chain fatty acids was observed. Furthermore, when plants transformed to express a long chain acyl-ACP thioesterase from mangosteen (GarmFatA1, U.S. patent application Ser. No. 08/440,845), which preferentially hydrolyzes C18:0 and C18:1 fatty acyl-ACPs, are crossed with nontransformed control plants, a significant reduction in the levels of C18:0 is obtained. Similar reductions are also observed in the levels of C18:0 in the seeds of plants resulting from crosses between plants transformed to express the GarmFatA1 and plants expressing the Cuphea hookeriana KAS A protein.

Thus, the instant invention provides methods of increasing and/or altering the medium-chain fatty acid compositions in transgenic plant seed oils by co-expression of medium-chain acyl-ACP thioesterases with synthase factor proteins. Furthermore, various combinations of synthase factors and medium-chain thioesterases may be achieved depending upon the particular fatty acids desired. For example, for increased production of C14 fatty acids, synthase protein factors may be expressed in combination with a C14 thioesterase, for example from Cuphea palustris or nutmeg may be employed (WO 96/23892). In addition, thioesterase expression may be combined with a number of different synthase factor proteins for additional effects on medium-chain fatty acid composition.

Synthases of use in the present invention include modified amino acid sequences, such as sequences which have been mutated, truncated, increased and the like, as well as such sequences which are partially or wholly artificially synthesized. The synthase protein encoding sequences provided herein may be employed in probes for further screening or used in genetic engineering constructs for transcription or transcription and translation in host cells, especially plant host cells. One skilled in the art will readily recognize that antibody preparations, nucleic acid probes (DNA and RNA) and the like may be prepared and used to screen and recover synthases and/or synthase nucleic acid sequences from other sources. Typically, a homologously related nucleic acid sequence will show at least about 60% homology, and more preferably at least about 70% homology, between the R. communis synthase and the given plant synthase of interest, excluding any deletions which may be present. Homology is determined upon comparison of sequence information, nucleic acid or amino acid, or through hybridization reactions.

Recombinant constructs containing a nucleic acid sequence encoding a synthase protein factor or nucleic acid sequences encoding a synthase protein factor and a medium-chain acyl-ACP thioesterase may be prepared by methods well known in the art. Constructs may be designed to produce synthase in either prokaryotic or eukaryotic cells. The increased expression of a synthase in a plant cell, particularly in conjunction with expression of medium-chain thioesterases, or decreasing the amount of endogenous synthase observed in plant cells are of special interest.

Synthase protein factors may be used, alone or in combination, to catalyze the elongating condensation reactions of fatty acid synthesis depending upon the desired result. For example, rate influencing synthase activity may reside in synthase I-type, synthase II-type, synthase III-type or in a combination of these enzymes. Furthermore, synthase activities may rely on a combination of the various synthase factors described herein.

Constructs which contain elements to provide the transcription and translation of a nucleic acid sequence of interest in a host cell are “expression cassettes”. Depending upon the host, the regulatory regions will vary, including regions from structural genes from viruses, plasmid or chromosomal genes, or the like. For expression in prokaryotic or eukaryotic microorganisms, particularly unicellular hosts, a wide variety of constitutive or regulatable promoters may be employed. Among transcriptional initiation regions which have been described are regions from bacterial and yeast hosts, such as E. coli, B. subtilis, Saccharomyces cerevisiae, including genes such as β-galactosidase, T7 polymerase, trp-lac (tac), trp E and the like.

An expression cassette for expression of synthase in a plant cell will include, in the 5′ to 3′ direction of transcription, a transcription and translation initiation control regulatory region (also known as a “promoter”) functional in a plant cell, a nucleic acid sequence encoding a synthase, and a transcription termination region. Numerous transcription initiation regions are available which provide for a wide variety of constitutive or regulatable, e.g., inducible, transcription of the desaturase structural gene. Among transcriptional initiation regions used for plants are such regions associated with cauliflower mosaic viruses (35S, 19S), and structural genes such as for nopaline synthase or mannopine synthase or napin and ACP promoters, etc. The transcription/translation initiation regions corresponding to such structural genes are found immediately 5′ upstream to the respective start codons. Thus, depending upon the intended use, different promoters may be desired.

Of special interest in this invention are the use of promoters which are capable of preferentially expressing the synthase in seed tissue, in particular, at early stages of seed oil formation. Examples of such seed-specific promoters include the region immediately 5′ upstream of a napin or seed ACP genes such as described in U.S. Pat. No. 5,420,034, desaturase genes such as described in Thompson et al (Proc. Nat. Acad. Sci. (1991) 88:2578-2582), or a Bce-4 gene such as described in U.S. Pat. No. 5,530,194. Alternatively, the use of the 5′ regulatory region associated with the plant synthase structural gene, i.e., the region immediately 5′ upstream to a plant synthase structural gene and/or the transcription termination regions found immediately 3′ downstream to the plant synthase structural gene, may often be desired. In general, promoters will be selected based upon their expression profile which may change given the particular application.

In addition, one may choose to provide for the transcription or transcription and translation of one or more other sequences of interest in concert with the expression or anti-sense of the synthase sequence, particularly medium-chain plant thioesterases such as described in U.S. Pat. No. 5,512,482, to affect alterations in the amounts and/or composition of plant oils.

When one wishes to provide a plant transformed for the combined effect of more than one nucleic acid sequence of interest, a separate nucleic acid construct may be provided for each or the constructs may both be present on the same plant transformation construct. The constructs may be introduced into the host cells by the same or different methods, including the introduction of such a trait by crossing transgenic plants via traditional plant breeding methods, so long as the resulting product is a plant having both characteristics integrated into its genome.

Normally, included with the DNA construct will be a structural gene having the necessary regulatory regions for expression in a host and providing for selection of transformed cells. The gene may provide for resistance to a cytotoxic agent, e.g. antibiotic, heavy metal, toxin, etc., complementation providing prototrophy to an auxotrophic host, viral immunity or the like. Depending upon the number of different host species into which the expression construct or components thereof are introduced, one or more markers may be employed, where different conditions for selection are used for the different hosts.

The manner in which the DNA construct is introduced into the plant host is not critical to this invention. Any method which provides for efficient transformation may be employed. Various methods for plant cell transformation include the use of Ti- or Ri-plasmids, microinjection, electroporation, liposome fusion, DNA bombardment or the like. In many instances, it will be desirable to have the construct bordered on one or both sides by T-DNA, particularly having the left and right borders, more particularly the right border. This is particularly useful when the construct uses A. tumefaciens or A. rhizogenes as a mode for transformation, although the T-DNA borders may find use with other modes of transformation.

The expression constructs may be employed with a wide variety of plant life, particularly plant life involved in the production of vegetable oils. These plants include, but are not limited to rapeseed, peanut, sunflower, safflower, cotton, soybean, corn and oilseed palm.

For transformation of plant cells using Agrobacterium, explants may be combined and incubated with the transformed Agrobacterium for sufficient time for transformation, the bacteria killed, and the plant cells cultured in an appropriate selective medium. Once callus forms, shoot formation can be encouraged by employing the appropriate plant hormones in accordance with known methods and the shoots transferred to rooting medium for regeneration of plants. The plants may then be grown to seed and the seed used to establish repetitive generations and for isolation of vegetable oils.

The invention now being generally described, it will be more readily understood by reference to the following examples which are included for purposes of illustration only and are not intended to limit the present invention.

EXAMPLES Example 1 Cuphea KAS Factor A and B Gene Cloning

Total RNA isolated from developing seeds of Cuphea hookeriana and Cuphea pullcherrima was used for cDNA synthesis in commercial 1-based cloning vectors. For cloning each type of KAS gene, approximately 400,000-500,000 unamplified recombinant phage were plated and the plaques transferred to nitrocellulose. For KAS factor B cloning from C. hookeriana, a mixed probe containing Brassica napus KAS factor B and Ricinus communis (Castor) KAS factor B radiolabeled cDNA's was used. Similarly, a mixed probe containing Brassica napus KAS factor A and Ricinus communes KAS factor A cDNA clones was used to obtain C. hookeriana KAS factor A genes. For KASIII, a spinach KASIII cDNA clone obtained from Dr. Jan Jaworski was radiolabeled and used as a probe to isolate a KASIII clone from C. hookeriana. For KAS B and KAS A cloning from C. pullcherrima, C. hookeriana KAS B and KAS A genes chKAS B-2 and chKAS A-2-7 (see below) were radiolabeled and used as probes.

DNA sequence and translated amino acid sequence for Cuphea KAS clones are provided in FIGS. 1-9. Cuphea hookeriana KAS factor B clones chKAS B-2 and chKAS B-31-7 are provided in FIGS. 1 and 2. Neither of the clones is full length. Cuphea hookeriana KAS Factor A clones chKAS A-2-7 and chKAS A-1-6 are provided in FIGS. 3 and 4. chKAS A-2-7 contains the entire encoding sequence for the KAS factor protein. Based on comparison with other plant synthase proteins, the transit peptide is believed to be represented in the amino acids encoded by nucleotides 125-466. chKAS A-1-6 is not a full length clone although some transit peptide encoding sequence is present. Nucleotides 1-180 represent transit peptide encoding sequence, and the mature protein encoding sequence is believed to begin at nucleotide 181.

Cuphea pullcherrima KAS factor B clones cpuKAS B/7-8 and cpuKAS B/8-7A are provided in FIGS. 5 and 6. Both of the clones contain the entire encoding sequences for the KAS factor B proteins. The first 35 amino acids of cpuKAS B/7-8 are believed to represent the transit peptide, with the mature protein encoding sequence beginning at nucleotide 233. The first 39 amino acids of cpuKAS B/8-7A are believed to represent the transit peptide, with the mature protein encoding sequence beginning at nucleotide 209. Cuphea pullcherrima KAS factor A clones cpuKAS A/p7-6A and cpuKAS A-p8-9A are provided in FIGS. 7 and 8. Both of the clones contain the entire encoding sequences for the KAS factor A proteins. Translated amino acid sequence of cpuKAS A/p7-6A is provided. The mature protein is believed to begin at the lysine residue encoded 595-597, and the first 126 amino acids are believed to represent the transit peptide. The DNA sequence of KAS A clone cpuKAS A-p8-9A is preliminary. Further analysis will be conducted to determine final DNA sequence and reveal the amino acid sequence encoded by this gene.

DNA and translated amino acid sequence of Cuphea hookeriana KASIII clone chKASIII-27 is provided in FIG. 9. The encoding sequence from nucleotides 37-144 of chKASIII-27 are believed to encode a transit peptide, and the presumed mature protein encoding sequence is from nucleotides 145-1233.

Deduced amino acid sequence of the C. hookeriana KAS factor B and KAS factor A cDNA's reveals strong homology to the Brassica napus and Ricinus communis clones previously reported. The C. hookeriana KAS factor B clone is more homologous to the Ricinus and Brassica KAS factor B clones (94% and 91% respectively) than it is to the Ricinus and Brassica KAS factor A clones (60% for both). Furthermore, the C. hookeriana KAS factor A clone is more homologous to the Ricinus and Brassica KAS factor A clones (85% and 82% respectively) than it is the Ricinus and Brassica KAS factor B clone (60% for both). The C. hookeriana KAS factor B cDNAs designated as chKAS B-2 and chKAS B-31-7 are 96% identical within the mature portion of the polypeptide. Similarly, the deduced amino acid sequence of the mature protein regions of the C. hookeriana KAS factor A clones chKAS A-2-7 and chKAS A-1-6 are 96% identical. The C. pullcherrima KAS clones also demonstrate homology to the R. communis and Brassica napus KAS clones. The mature protein portion of all of the KAS factor A family members in the different Cuphea species are 95% identical. Similarly the mature protein portion of the KAS factor B genes in Cuphea are also 95-97% identical with each other. However there is only approximately 60% sequence identity between KAS factor B and KAS factor A clones either within the same or different species of Cuphea.

Example 2 Levels and Patterns of Expression

To examine tissue specificity of KAS expression in Cuphea hookeriana, Northern blot analysis was conducted using total RNA isolated from seed, root, leaf and flower tissue. Two separate but identical blots were hybridized with either chKAS B-31-7 or chKAS A-2-7 coding region probes. The data from this RNA blot analysis indicate that KAS B is expressed at a similar level in all tissues examined, whereas KAS A expression is detected only in the seed. These results also demonstrate a different level of expression for each of the synthases. KAS A is an abundant message, whereas KAS B is expressed at low levels. Furthermore, even under highly stringent hybridization conditions (65_C, 0.1×SSC, 0.5% SDS), the KAS A probe hybridizes equally well with two seed transcripts of 2.3 and 1.9 kb. The larger hybridizing band is likely the transcript of the KAS A-2-7 gene since the size of its cDNA is 2046 bp, and the number of clones obtained from cDNA screening corresponds well with the apparent mobility of the mRNA and its abundance on the blot.

Example 3 Expression of Plant KAS Genes in E. coli

DNA fragments encoding the mature polypeptide of the Cuphea hookeriana KAS A cDNAs and the Cuphea pullcherrima KAS B cDNAs were obtained by PCR and cloned into a QIAexpress expression vector (Qiagene). Experimental conditions for maximum level of expression were determined for all of these clones and the parameters for highest level of soluble fraction were identified. Cells are grown in ECLB media containing 1M sorbitol and 2.5 mM betaine overnight and subcultured as a 1:4 dilution in the same medium. Cells are then grown for 2 hours (to approximately 0.6-0.8 O.D.) and induced with 0.4 mM IPTG and allowed to grow for 5 more hours.

Enzyme activity of the affinity purified recombinant enzymes obtained from over-expression of the chKAS A-2-7 and cpuKAS B/8-7A clones was measured using a wide range of acyl-ACP substrates (6:0- to 16:1-ACP). The activity profile for cpuKAS B/8-7A is provided in FIG. 10. The data demonstrate that the enzyme is active with all acyl-ACP substrates examined, although activity on 6:0 to 14:0-ACP substrates is substantially greater than the activity on 16:0 and 16:1 substrates.

The activity profile of the C. hookeriana KAS A clones chKAS A-2-7 and chKAS A-1-6 is provided in FIG. 11. The C. hookeriana KAS A clones are most active with C:6, and have the least activity with C:16:0 substrates. However, the activity of this clone on even the preferred C6:0 substrate is 50 fold lower than the activity of the C. pullcherrima KAS B clones.

A fragment containing the mature protein encoding portion of a R. communis KAS factor A clone was also cloned into a QIAexpress expression vector, expressed in E. coli and the enzyme affinity purified as described above. The activity profile for castor KAS A is provided in FIG. 12. Highest activity is observed with C14:0 substrates, although some activity is also seen with C6:0 and C16:1. In comparison, the activity profile obtained from purified R. communis KAS factor B also using the QIAexpress expression system is provided in FIG. 13. The KAS B clone demonstrates substantially higher levels of activity (10 fold and higher) than the R. communis KAS A clone. The preference of the KAS factor B for 6:0- to 14:0-ACP substrates is consistent with the previous observations that this protein provides KAS I activity.

Example 4 KAS and TE Expression in Transgenic Seed

Both the CpFatB1 (C. hookeriana thioesterase cDNA; Dehesh et al. (1996) Plant Physiol. 110:203-210) and the chKAS A-2-7 were PCR amplified, sequenced, and cloned into a napin expression cassette. The napin/cp FatB1 and the napin/KAS A-2-7 fusions were ligated separately into the binary vector pCGN1558 (McBride and Summerfelt (Pl. Mol. Biol. (1990) 14:269-276) and transformed into A. tumefaciens, EHA101. The resulting CpFatB1 binary construct is pCGN5400 and the chKAS A-2-7 construct is pCGN5401. Agrobacterium mediated transformation of a Brassica napus canola variety was carried out as described by Radke et al. (Theor. Appl. Genet. (1988) 75:685-694; Plant Cell Reports (1992) 11:499-505). Several transgenic events were produced for each of the pCGN5400 and PCGN5401 constructs.

A double gene construct containing a napin/cpFatB1 expression construct in combination with a napin/chKAS A-2-7 expression construct was also assembled, ligated into a binary vector and used for co-cultivation of a canola Brassica variety. The binary construct containing the CpFatB1 and chKAS A-2-7 expression constructs is pCGN5413.

Fatty acid analysis of 26 transgenic lines containing chKAS A-2-7 (5401 lines) showed no significant changes in the oil content or profile as compared to similar analyses of wild type canola seeds of the transformed variety.

Fatty acid analysis of 36 transgenic lines containing CpFatB1 (5400 lines) showed increased levels of C:8 and C:10 in transgenic seeds. The highest level of C:8 observed in a pool seed sample was 4.2 mol %. The C:10 levels were between 30 and 35% of the C:8 content. Fatty acid analysis of 25 transgenic lines containing the TE/KAS A tandem (5413 lines) demonstrated an overall increase in both C:8 and C:10 levels relative to those observed with TE containing lines (5400) alone. In lines containing the CpFatB1 construct alone, the average level of C:8 average were 1.5 mol %, whereas the C:8 average levels in TE/KAS A tandem containing lines was 2.37 mol %. The ratio of C:8 to C:10 remained constant in both populations. The number of transgenic events relative to the C:8 content are presented in FIG. 14. These data show that the transgenic events with tandem TE/KAS A construct yield more lines with higher levels of C:8 than those events with single TE construct. For example, several lines containing nearly 7 mole % C8 were obtained with the TE/KAS A pCGN5413 construct, whereas the highest C8 containing line from the pCGN5400 TE alone transformation contained 4.2 mole % C8.

Half seed analysis of the T3 generation of transgenic canola plants expressing a ChFatB2 (C. hookeriana thioesterase; Dehesh et al. (1996) The Plant Journal 9:167-172) indicate that these plant can accumulate up to 22 weight % (33 mol %) of 8:0 and 10:0 fatty acids (4804-22-357). Segregation analysis shows that these transformants contain two loci and that they are now homozygous. Selected plants grown from these half seeds were transferred into the greenhouse and later crossed with T1 transformants that had been transformed with either Cuphea hookeriana KAS A (5401) alone or KAS A/CpFatB1 double constructs (5413).

Fatty acid analysis of several events resulting from the crosses between transgenic lines containing ChFatB2 (4804-22-357) and chKAS A-2-7 (5401-9), reveal an increase in the ratio of C:10/C:8 levels (FIGS. 15A and 15B). This C:10/C:8 ratio in nearly all of the transgenic events containing ChFatB2 TE alone fluctuates between 3 and 6, whereas in the F1 generation of transgenic containing both the TE and the KAS A-2-7, the ratio can be as high as 22. This increase in C:10 levels is accompanied by an increase in the total C:8 and C:10 content (FIGS. 16A and 16B). The sum of the C:8 and C:10 fatty acids in the heterozygous F1 lines is as high as those in the homozygous parent line (4804-22-357), whereas the heterozygous lines usually contain substantially less C:8 and C:10 than the homozygous lines.

Similar results were observed in F1 generation seeds resulting from crosses performed between 4804-22-357 (ChFatB2) and the 5413-17 event (CpFatB1 and chKAS A-2-7 tandem). Levels of C:8 and C:10 in the 5413-17 line were 6.3 and 2.8 mol % respectively. Data presented in FIGS. 17A and 17B show that there is shift towards C:10 fatty acids as was observed with the 4804-22-357 (ChFatB2)×5401-9 (chKAS A-2-7) crosses. Furthermore, FIGS. 18A and 18B indicates the presence of two separate populations of heterozygotes. Those containing approximately 9-11 weight percent C:10+C:8 are believed to represent offspring containing a single copy of the ChFatB1 TE gene and no copies of the CpFatB1 and chKAS A genes from 5413. Those plants containing approximately 15-20 weight percent C:10+C:8 are believed to represent the heterozygotes containing a single ChFatB1 TE gene as well as the CpFatB1 and chKAS A genes from 5413. Thus, the level of the C:10+C:8 fatty acids does not decrease to 50% of that detected in parent lines when a copy of the ChKAS A gene is present.

To further characterize the chain length specificity of the Cuphea hookeriana KAS A enzyme, crosses between transgenic Brassica napus lines containing a California Bay (Umbellularia californica) 12:0 specific thioesterase, Uc FatB1 (U.S. Pat. No. 5,344,771) and chKAS A-2-7 (5401-9) were made. Half seed analysis of transgenic plants containing Uc fatB1 have previously indicated that these plants can accumulate up to 52 mol % C12:0 in the seed oil of homozygous dihaploid lines (LA86DH186). Crosses between the line LA86DH186 and untransformed control Brassica demonstrated a decrease in the C12:0 levels.

However, crosses between LA86DH186 and the 5401-9 hemizygous line led to an accumulation of up to 57 mol % C12:0 in the seed oil of F1 progeny (FIGS. 19A, 19B, and 19C). Interestingly, in crosses with LA86DH186 x untransformed control line and LA86DH186×5401-9, levels of C14:0 in the seeds of the F1 progeny decreased to 50% of the levels obtained in homozygous LA86DH186 lines (FIG. 20). Furthermore, increases in the proportion of C12:0 fatty acid resulted in a substantial decline in the proportions of all the long-chain fatty acyl groups (C16:0, C18:0, C18:2, and C18:3). These results indicate that the ChKAS A-2-7 is an enzyme with substrate specificity ranging from C6:0 to C10:0-ACP, and that its over-expression ultimately reduces the longer chain acyl-ACP pools.

Further evidence is obtained in support of the chain length specificity of the ChKAS A-2-7 in crosses of the 5401-9 line with a transgenic line (5266) expressing an 18:1/18:0 TE from Garcinia mangostana (GarmFatA1, U.S. patent application Ser. No. 08/440,845). Transgenic Brassica line 5266 has been shown to accumulate up to 24 mol % C18:0 in the seed oil of homozygous lines (FIGS. 21A, 21B, and 21C). However, in the seed oil of F1 progeny of crosses between 5266 and 5401-9 levels of C18:0 were reduced to approximately 12 mol %. Furthermore, levels of C16:0 generated from these crosses was similar to the levels obtained from the seed oil of nontransgenic control plants.

Example 5 In vitro Analysis of Plant KAS Enzymes

Seed extracts were prepared from developing seeds of nontransgenic controls or transgenic Brassica expressing chKAS A-2-7 as described in Slabaugh et al. (Plant Journal, 1998 in press) and Leonard et al. (Plant Journal, 1998, in press). In vitro fatty acid synthesis assays were performed as described by Post-Beittenmiller (J. Biol. Chem. (1991), 266:1858-1865). Extracts were concentrated by ammonium sulfate precipitation and desalting using P-6 columns (Bio-Rad, Hercules, Calif.). Reactions (65 μl) contained 0.1M Tris/HCl (pH 8.0), 1 mM dithiothreitol, 25 mM recombinant spinach ACP1, 1 mM NADH, 2 mM NADPH, 50 μM malonyl-CoA, 10 μM (1-¹⁴C]acetyl-CoA (50 mCi/mmol), 1 mg/ml BSA, and 0.25 mg/ml seed protein. Selected seed extracts were preincubated with cerulenin at 23° C. for 10 min. Reaction products were separated on an 18% acrlamide gel containing 2.25M urea, electroblotted onto to nitrocellulose and quntitated by phosphorimaging using Image QuaNT software (Molecular Dynamics, Sunnyvale, Calif.). Authentic acyl-ACPs were run in parallel, immunoblotted and finally detected by anti-ACP serum to confirm fatty acid chain lengths.

The results (FIG. 22) indicate that the fatty acid synthesis capabilities of transgenic Brasica (5401-9) seed extracts was greater than that obtained from in the nontransgenic controls as measured by the relative abundance of C8:0- and C10:0-ACP at all time points tested. In addition, pretreatment of the extracts with cerulenin, markedly reduced the synthesis of longer chain fatty acids in both the transgenic and nontransgenic control seed extracts. However, the extension of the spinach-ACP was much less inhibited in the seed extracts from the transgenic lines than in the seed extracts of nontransgenic control Brassica.

These data further support that Ch KAS A-2-7 is a condensing enzyme active on medium chain acyl-ACPs, and that expression of this enzyme in plants results in enlarged substrate pools to be hydrolyzed by medium-chain specific thioesterases. Furthermore, these data suggest that chKAS A-2-7 also is a cerulenin-resistant condensing enzyme.

All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claim. 

1. A plant seed comprising a coding sequence for a medium-chain thioesterase protein, and a coding sequence for a β-ketoacyl-ACP synthase (KAS) protein, wherein the composition of medium-chain fatty acids produced in said plant seed is modified.
 2. The plant seed according to claim 1, wherein said KAS protein is a KAS factor A protein.
 3. The plant seed according to claim 1, wherein said KAS protein is a KAS factor B protein.
 4. The plant seed according to claim 1, wherein said plant seed composition is modified as compared to the composition of medium-chain fatty acids produced in plant seed expressing said medium-chain thioesterase protein in the absence of expression of said KAS protein.
 5. The plant seed of claim 1, wherein said KAS factor protein is from a Cuphea species.
 6. The plant seed of claim 1, wherein said KAS factor protein comprises a coding sequence as set forth in SEQ ID NO:5.
 7. The plant seed of claim 1, wherein said KAS factor protein comprises a coding sequence encoding an amino acid sequence as set forth in SEQ ID NO:6.
 8. The plant seed of claim 1, wherein said KAS factor protein comprises a coding sequence encoding an amino acid sequence set forth in residues 125-466 of SEQ ID NO:6.
 9. The plant seed of claim 1, wherein said fatty acid composition is enriched for C10 fatty acids.
 10. The plant seed of claim 1, wherein said fatty acid composition is enriched for C12 fatty acids.
 11. The plant seed of claim 1, wherein said fatty acid composition is enriched for at least one medium chain fatty acid and at least one other medium chain fatty acid is decreased.
 12. The plant seed of claim 11, wherein said fatty acid composition has an increased ratio of C10 fatty acids to C8 fatty acids relative to the composition of medium-chain fatty acids produced in plant seed expressing said medium-chain thioesterase protein in the absence of expression of said KAS protein.
 13. The plant seed of claim 11, wherein said fatty acid composition has an increased total content of C10 fatty acids and C8 fatty acids relative to the composition of medium-chain fatty acids produced in plant seed expressing said medium-chain thioesterase protein in the absence of expression of said KAS protein.
 14. The plant seed of claim 1, wherein said thioesterase protein is selected from the group consisting of Cuphea hookeriana FatB2, Cuphea pulcherrima FatB1, Umbellularia californica FatB1, and Garcinia mangostana FatA1.
 15. A plant seed exhibiting a seed oil fatty acid composition comprising a C10 fatty acid to C8 fatty acid ratio as high as 22, wherein said seed comprises comprising a coding sequence for a medium-chain thioesterase protein and a coding sequence for a β-ketoacyl-ACP synthase (KAS) factor.
 16. The plant seed according to claim 15, wherein said KAS protein is a KAS factor A protein.
 17. The plant seed according to claim 15, wherein said KAS protein is a KAS factor B protein.
 18. The plant seed of claim 15, wherein said C10 fatty acid to C8 fatty acid ratio is higher as compared to the C10 fatty acid to C8 fatty acid ratio produced in seeds expressing said plant medium-chain thioesterase protein in the absence of expression of said KAS factor protein.
 19. The plant seed of claim 15, wherein said C10 fatty acid to C8 fatty acid ratio is between 7 and
 22. 20. The plant seed of claim 15, wherein said C10 fatty acid to C8 fatty acid ratio is between 7 and
 16. 21. The plant seed of claim 12, wherein said KAS factor protein is from a Cuphea species.
 22. A plant seed exhibiting a seed oil fatty acid composition enriched for at least one medium chain fatty acid and at least one other medium chain fatty acid is decreased, wherein said seed comprises a coding sequence for a medium-chain thioesterase protein and a coding sequence for a β-ketoacyl-ACP synthase (KAS) factor protein.
 23. The plant seed according to claim 22, wherein said KAS protein is a KAS factor A protein.
 24. The plant seed according to claim 22, wherein said KAS protein is a KAS factor B protein.
 25. The plant seed of claim 22, wherein said enriched fatty acid is C12 and said decreased fatty acid is C14.
 26. The plant seed of claim 22, wherein said seed oil comprises up to 57 mol % C12:0.
 27. The plant seed of claim 22, wherein said seed oil comprises between 34 and 50 weight percent of C12:0.
 28. The plant seed of claim 22, wherein said decreased fatty acid is C18:0.
 29. The plant seed of claim 22, wherein said C18:0 levels are decreased to approximately 12 mol %.
 30. A seed oil fatty acid composition comprising a modified level of medium-chain fatty acids, wherein said seed oil is derived from a transgenic plant comprising a coding sequence for a medium-chain thioesterase protein and a coding sequence for a β-ketoacyl-ACP synthase (KAS) factor protein.
 31. The seed oil according to claim 30, wherein said KAS protein is a KAS factor A protein.
 32. The seed oil according to claim 30, wherein said KAS protein is a KAS factor B protein.
 33. The seed oil according to claim 30, wherein said seed oil is modified as compared to the composition of medium-chain fatty acids produced in plant seed expressing said medium-chain thioesterase protein in the absence of expression of said KAS protein.
 34. The seed oil according to claim 30, wherein said KAS factor protein is from a Cuphea species.
 35. The seed oil according to claim 30 comprising a C10 fatty acid to C8 fatty acid ratio as high as
 22. 36. The seed oil of claim 35, wherein said C10 fatty acid to C8 fatty acid ratio is between 7 and
 22. 37. The seed oil of claim 35, wherein said C10 fatty acid to C8 fatty acid ratio is between 7 and
 16. 38. The seed oil of claim 30, wherein said fatty acid composition is enriched for at least one medium chain fatty acid and at least one other medium chain fatty acid is decreased.
 39. The seed oil of claim 38, wherein said enriched fatty acid is C12 and said decreased fatty acid is C14.
 40. The seed oil of claim 38, wherein said seed oil comprises up to 57 mol % C12:0.
 41. The seed oil of claim 38, wherein said seed oil comprises between 34 and 50 weight percent of C12:0.
 42. The seed oil of claim 38, wherein said decreased fatty acid is C18:0.
 43. The seed oil of claim 38, wherein said C18:0 levels are decreased to approximately 12 mol %. 